COLUMBUS, Ind. – Columbus Regional Health (CRH) is providing a trial therapy option available for high-risk hospitalized COVID-19 positive patients. It is made possible through a partnership with the Mayo Clinic and Versiti, a national blood research institute.
CRH is an official participant in the Expanded Access to Convalescent Plasma Program, which is designed to provide plasma from donors who have recovered from COVID-19 to critical patients suffering from the disease. Plasma from recovered Coronavirus patients contains antibodies that help fight COVID-19.
“We are pleased to partner with Mayo Clinic and Versiti Blood Bank to offer this potentially life-preserving treatment to our most vulnerable patients,” said Dr. Raymond Lee Kiser. “This therapy has shown great progress nationally in helping critically ill patients in the recovery of COVID-19.”
CRH is seeking potential eligible donors for the program who can donate at a Versiti Blood Bank location in Indianapolis. Their plasma will be used to treat patients in the Bartholomew County area.
